Drug Shortage Report for NOREPINEPHRINE BITARTRATE INJECTION USP
Report ID | 159863 |
Drug Identification Number | 02485680 |
Brand name | NOREPINEPHRINE BITARTRATE INJECTION USP |
Common or Proper name | Norepinephrine Bitartrate Injection |
Company Name | GENERIC MEDICAL PARTNERS INC |
Market Status | MARKETED |
Active Ingredient(s) | NOREPINEPHRINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1mg/ml 4 ml ampoule, pack of ten ampoules |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-05-02 |
Actual start date | 2022-05-02 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-09-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-09-14 | French | Compare |
v8 | 2022-09-14 | English | Compare |
v7 | 2022-05-03 | English | Compare |
v6 | 2022-05-02 | French | Compare |
v5 | 2022-05-02 | English | Compare |
v4 | 2022-05-02 | French | Compare |
v3 | 2022-05-02 | French | Compare |
v2 | 2022-05-02 | English | Compare |
v1 | 2022-05-02 | English | Compare |
Showing 1 to 9 of 9